United States
ByteBrain Launches MEDRAIL: AI System to Accelerate and Safeguard Clinical Trials
ByteBrain launches MEDRAIL, an AI-powered platform designed to support faster, safer, and more compliant clinical trials across the pharmaceutical industry
Sheridan, Wyoming, June 05, 2025 (GLOBE NEWSWIRE) — . Based in the U.S., it combines consulting services with the development of advanced IP in healthcare, finance, and enterprise AI systems. MEDRAIL is the firm’s flagship healthtech innovation and part of its broader mission to build human-centered, compliance-ready AI solutions.
CONTACT: Priyanshu Sharma | [email protected] ByteBrain [email protected] www.thebytebrain.com
